| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | WO2004024078A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024074A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | WO2004024073A2 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin |
| 03/25/2004 | WO2004024069A2 Novel compositions and methods for the treatment of immune-related diseases |
| 03/25/2004 | WO2004024066A2 Method of treating diabetes and related conditions |
| 03/25/2004 | WO2004024065A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024061A2 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 03/25/2004 | WO2004023984A2 Novel composition and method for treatment of upper respiratory conditions |
| 03/25/2004 | WO2004023899A1 Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses |
| 03/25/2004 | WO2004023889A2 Full range nutritional supplements from plant materials and methods for their manufacture |
| 03/25/2004 | WO2004014367A3 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2004013134A3 Compounds |
| 03/25/2004 | WO2004005237B1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same |
| 03/25/2004 | WO2004004697A3 A novel use of rapamycin and structural analogues thereof |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004004638A3 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2004000801A3 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/25/2004 | WO2004000358B1 Transdermal drug delivery system |
| 03/25/2004 | WO2004000214A3 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions |
| 03/25/2004 | WO2003105923A3 Use of y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation |
| 03/25/2004 | WO2003105840A3 Sphingosine kinase inhibitors |
| 03/25/2004 | WO2003105826B1 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 03/25/2004 | WO2003105780A3 A dry powder oligonucleotide formulation, preparation and its uses |
| 03/25/2004 | WO2003105752A3 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate) |
| 03/25/2004 | WO2003105605A3 Use of pullulan as a slowly digested carbohydrate |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003103681A3 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema |
| 03/25/2004 | WO2003103676A3 Method of treating cancer using kinase inhibitors |
| 03/25/2004 | WO2003103675A3 Combination treatments for purinoceptor-related disorders |
| 03/25/2004 | WO2003103603A3 Novel formate salt of o-desmethyl-venlafaxine |
| 03/25/2004 | WO2003101434A3 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 03/25/2004 | WO2003098992A3 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 03/25/2004 | WO2003095665A3 Pmea and pmpa cyclic producing synthesis |
| 03/25/2004 | WO2003094842A3 Conjugates comprising central nervous system active drug |
| 03/25/2004 | WO2003092669A3 Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac |
| 03/25/2004 | WO2003092591A3 Multi-phasic delivery via transmucosal absorption of antiemetic medicaments |
| 03/25/2004 | WO2003088996A3 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003086392A3 Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 03/25/2004 | WO2003086372A3 Methods of treating medication-, substance-, disease-, and other medical condition-related sexual dysfunction |
| 03/25/2004 | WO2003086318A3 Improved prodrugs of cc-1065 analogs |
| 03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
| 03/25/2004 | WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003084926A3 Polymeric acyl derivatives of indoles |
| 03/25/2004 | WO2003082283A3 Pharmaceutical composition with combined active agents and methods for using the same |
| 03/25/2004 | WO2003082271A3 Indole derivatives having anti-angiogenetic activity |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003080624A3 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003077869A3 Neuroprotective spirostenol pharmaceutical compositions |
| 03/25/2004 | WO2003077862A3 Potent, simplified derivatives of immunosuppressive agents |
| 03/25/2004 | WO2003077842A3 Palatable oral suspension and method |
| 03/25/2004 | WO2003075903A3 Use proline and its functional equivalentsfor quenching ros and/ or radicals |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003074108A3 Compositions for generating submucosal fluid cushions |
| 03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/25/2004 | WO2003070163A3 Prostacyclin derivatives for treating cancer |
| 03/25/2004 | WO2003068200A3 Novel therapeutic application for a composition |
| 03/25/2004 | WO2003066104A3 Pharmaceutical composition which improves in vivo gene transfer |
| 03/25/2004 | WO2003063858A3 Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 03/25/2004 | WO2003063805A3 Cosmetic or dermatological use of vitamin a or the esters thereof in combination with a partly methylated beta-cyclodextrin |
| 03/25/2004 | WO2003061378A3 Synergistic mixtures of o-phenylphenol and other microbiocides |
| 03/25/2004 | WO2003059372A3 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 03/25/2004 | WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 03/25/2004 | WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 03/25/2004 | WO2003047567A8 STABLE, ACID, AQUEOUS SOLUTION CONTAINING α-LIPONIC ACID (DERIVATIVES), METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME |
| 03/25/2004 | WO2003047558A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
| 03/25/2004 | WO2003045365A3 Sphingosine derivative as an immunoregulator compound |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003039519A3 Dual controlled release dosage form |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003037860A3 Purine analogs having hsp90-inhibiting activity |
| 03/25/2004 | WO2003028633A3 Parenteral delivery systems |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2003024298A3 Interspinous process implant sizer and distractor with a split head and size indicator and method |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | WO2003000343A3 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002089797A8 Treatment of adhd |
| 03/25/2004 | WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002074290B1 Dermatological preparations containing a nsaid |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002060381A3 Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function |
| 03/25/2004 | WO2002039998A3 Methods and compositions for regulating memory consolidation |